[ET Net News Agency, 30 March 2020] Sino Biopharmaceutical Limited (01177) said for the
year ended 31 December 2019, profit attributable to the owners of the parent was
RMB2,706.79 million, 70.1% lower than that of the last year. Basic earnings per share a
were RMB21.58 cents. The board has recommended the payment of a final dividend of HK2
cents per share.
Revenue was RMB24,234.03 million, an increase of 16% over the last year. (RC)